Pollinosis — an allergic reaction to pollen — was independently linked to an increased likelihood of having obstructive sleep apnea-hypopnea syndrome (OSAHS), and this association was stable ...

Although sublingual immunotherapy (SLIT) has become an effective treatment option for many allergies, about 20–30% of patients don't respond to SLIT for Japanese cedar pollinosis—a highly ...

An epidemiological survey covering otolaryngologists and their family members showed that 38.8 percent were affected with cedar pollinosis in 2019, sharply up from 16.2 percent in 1998.

The study, “The impact of omalizumab on paid and unpaid work productivity among severe Japanese cedar pollinosis (JCP) patients”, was published in the February 2022 edition of the renowned ...

Under the agreement, Astellas is responsible to develop and commercialize JRC2*-LAMP-vax in Japan, where Japanese red cedar pollinosis is endemic. Immunomic Therapeutics will receive $15 million ...